Investigating the Effect of Dietary Supplement VSL#3 on Cognition and Mood in Healthy Older Adults
NCT01877967 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 80
Last updated 2015-05-27
Summary
This research aims to determine whether a 12 week daily dose of VSL#3 has any measurable effects on memory, attention, executive function or self-reported mood and anxiety in healthy older adults.
Conditions
- Alteration of Cognitive Function
- Disturbance in Affect (Finding)
Interventions
- DIETARY_SUPPLEMENT
-
VSL#3
The intervention group will be asked to ingest two sachets (2x4.4g) of the food supplement (VSL#3) each day for 12 weeks, either both at the same time, or one in the morning and one in the evening. This food supplement is in powder form and can be ingested with either cold food or any non-carbonated cold drink. The control group will be given a placebo, although as it is a double-blind intervention, will not know it is a placebo. They will similarly to the intervention group be asked to take two sachets (2x4.4g) of a powder rach day for 12 weeks, either both at the same time, or one in the morning and one in the evening.
- DIETARY_SUPPLEMENT
-
placebo
Sponsors & Collaborators
-
Actial Farmaceutica S.r.l.
collaborator INDUSTRY -
University of Dublin, Trinity College
lead OTHER
Principal Investigators
-
Brian Lawlor · University of Dublin, Trinity College
Study Design
- Allocation
- RANDOMIZED
- Purpose
- PREVENTION
- Masking
- TRIPLE
- Model
- PARALLEL
Eligibility
- Min Age
- 65 Years
- Max Age
- 75 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2013-05-31
- Primary Completion
- 2015-04-30
- Completion
- 2015-07-31
Countries
- Ireland
Study Locations
More Related Trials
-
A Clinical Trial to Investigate the Efficacy of a Supplement to Improve and Maintain Cognitive Function and Memory
NCT06523218 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
To Access the Effect of Brain Pill™ on Working Memory Capacity and Mood Behaviour.
NCT03198936 ·Status: COMPLETED ·Phase: NA
-
A Phase 1 (First in Human) Randomized, Double-blind, Placebo-controlled SAD, MAD Study With Oral REM0046127
NCT04672135 ·Status: COMPLETED ·Phase: PHASE1
-
Effects of an Adaptogenic Extract on Electrical Activity of the Brain in Elderly Subjects With Cognitive Impairment
NCT03780621 ·Status: COMPLETED ·Phase: PHASE1
-
The Memory and Cognitive Performance Study
NCT04025255 ·Status: COMPLETED ·Phase: NA
-
Healthy Adults With Mild Cognitive Impairment (MCI) and a 16-week Intervention With Mitocholine™, a Functional Food Ingredient
NCT05690724 ·Status: RECRUITING ·Phase: NA
-
Polyamine-enriched Diet in Elderly Individuals With Subjective Cognitive Decline
NCT03094546 ·Status: COMPLETED ·Phase: PHASE2
-
Cognitive Effects of Citicoline on Attention in Healthy Mean and Women
NCT04967157 ·Status: COMPLETED ·Phase: NA
-
A Double-Blind, Placebo-Controlled Safety and Efficacy Study of NA-831
NCT03538522 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety of Eriobotyra Japonica Lindley Extract on Improvement of Cognitive Function
NCT01734200 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
The Efficacy of Phosphatidylserine-Omega3 in Elderly Subjects With Memory Impairment
NCT00736034 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy and Safety of Ginkgo Biloba in Middle-aged Cognitively Intact Adults
NCT02181972 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy of MEMORMAX in Subjects With MCI
NCT03581929 ·Status: COMPLETED ·Phase: NA
-
INSIDE: Intervention in Nutritional Supplementation to Improve Cognitive Decline in Elderly.
NCT07000500 ·Status: ENROLLING_BY_INVITATION ·Phase: NA
-
Efficacy and Safety of Piracetam Taken for 12 Months in Subjects Suffering From Mild Cognitive Impairment (MCI)
NCT00567060 ·Status: COMPLETED ·Phase: NA
-
Effects of Fermented Codonopsis Lanceolata on Improvement in Cognitive-Bio-Markers of Cognitive Functions
NCT03439098 ·Status: COMPLETED ·Phase: NA
-
A Study to Evaluate The Effects Of a Multivitamin/Mineral With Ginko In Subjects With Age Associated Memory Impairment
NCT01160692 ·Status: COMPLETED ·Phase: PHASE3
-
Study of the Effects of Cerefolin NAC on Inflammation Blood Markers in Older Individuals With Memory Complaints
NCT00597376 ·Status: COMPLETED ·Phase: NA
-
Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild to Moderate Alzheimer's Disease
NCT01689246 ·Status: COMPLETED ·Phase: PHASE3
-
Cognitive Effects of Citicoline in Men and Women With Age-Associated Memory Impairment
NCT03369925 ·Status: COMPLETED ·Phase: NA
-
Efficacy and Safety of 26-Week Treatment of AR1001 in Patients With Mild to Moderate Alzheimer's Disease
NCT03625622 ·Status: COMPLETED ·Phase: PHASE2
-
Effect of a Plant Based Nootropic on Perceptual Decision Making.
NCT06689644 ·Status: COMPLETED ·Phase: NA
-
Clinical Effectiveness of Choline Alphoscerate for Older Adults With Major Depression and Subjective Memory Complaints
NCT05257902 ·Status: UNKNOWN ·Phase: NA
-
A Study of Seltorexant in Participants With Probable Alzheimer's Disease
NCT05307692 ·Status: COMPLETED ·Phase: PHASE2
-
A Clinical Study to Assess the Effect of Tisina Complex on Cognitive Health in Individuals With Mild Cognitive Impairment
NCT06859346 ·Status: COMPLETED ·Phase: NA